Cohance Lifesciences Limited
COHANCE
Kedudukan dalam Saham
#6386
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Harga Saham
$5.05
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$1.93B
Perubahan (1 hari)
-1.44%
Perubahan (1 tahun)
-57.38%
Negara
IN
Perdagangan Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Pendapatan untuk Cohance Lifesciences Limited (COHANCE)
Pendapatan pada Jun 2025 TTM: $37.76M
Menurut laporan kewangan terkini Cohance Lifesciences Limited, pendapatan semasa syarikat ialah $37.76M. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $48.65M, penurunan berbanding pendapatan pada tahun 2023 yang berjumlah $68.11M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Cohance Lifesciences Limited dari 2019 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $37.76M | -6.11% |
| 2025 | $40.21M | -17.35% |
| 2024 | $48.65M | -28.57% |
| 2023 | $68.11M | -22.55% |
| 2022 | $87.95M | 37.66% |
| 2021 | $63.89M | 18.98% |
| 2020 | $53.70M | 136.19% |
| 2019 | $22.73M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 4,573.48% |
IN
|
